
GLP-1
Semaglutide is a GLP-1 (glucagon-like peptide-1) receptor agonist — a GLP-1 therapy associated with the body's natural pathways for appetite regulation, satiety, and metabolic balance. GLP-1 therapies have become some of the most widely discussed approaches in modern weight-management and metabolic wellness conversations.
This GLP-1 approach is associated with appetite signaling, satiety support, and discussions around healthy body composition and metabolic wellness. It is often explored as part of broader, provider-guided strategies focused on sustainable weight management, making GLP-1 therapy one of the most recognized categories in this space.
Choose options



How It Works
Why People Are Interested
Benefits
Who Can Benefit
Why Evaluation Matters
Treatment Process
Every program at Evolve follows a structured clinical model:
Comprehensive testing reveals your current physiology
Patterns, imbalances, and risk markers are identified
Treatment is selected based on objective data
Ongoing testing ensures safety and effectiveness
Schedule a Peptide Consultation
Discuss whether this approach may be appropriate as part of your personalized care plan.
